Lethal and mutagenic interactions between γ-rays, cisplatin and etoposide at the cellular and molecular levels

International Journal of Radiation Biology

Volumn 87, Issue 2, 2011, Pages 222-230

  Lillo, Olga ^a   Bracesco, Nelson ^a   Nunes, Elia ^a  

^a DEPARTAMENTO DE BIOQUÍMICA   (Uruguay)

Author keywords

cellular radiobiology; chemo radiotherapy; DNA repair; drug radiation interactions; mutant frequency

Indexed keywords

CISPLATIN; DOUBLE STRANDED DNA; ETOPOSIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DNA DEGRADATION; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DRUG CYTOTOXICITY; DRUG POTENTIATION; FUNGAL CELL; GAMMA RADIATION; HOMOLOGOUS RECOMBINATION; LETHALITY; MOLECULAR INTERACTION; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SACCHAROMYCES CEREVISIAE;

EUKARYOTA; SACCHAROMYCES CEREVISIAE;

EID: 79551642544     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553002.2010.518207     Document Type: Article

References (42)

1. Ager DD, Haynes RH. 1990. Analysis of interactions between mutagens. Heat and ultraviolet light in Saccharomyces cerevisiae. Mutation Research 212:313-326.
2. Auclair Y, Rouget R, Affar EB, Drobetsky EA. 2008. ATR kinase is required for global genomic nucleotide excision repair exclusively during S phase in human cells. Proceedings of the National Academy of Sciences of the USA 105(46):17896-17901.
3. Benathen A, Beam CA. 1977. The genetic control of X-Ray resistance in budding yeast cells. Radiation Research 69:99-116.
4. Bergink S, Jentsch S. 2009. Principles of ubiquitin and SUMO modifications in DNA repair. Nature 458:461-467.
5. Bonner JA, Garces YJ, Buchsbaum DJ. 2007. Interaction of chemotherapy and radiation. In: Leonard L, Gunderson JE, Tepper JR, editors. Clinical radiation oncology. 2nd ed. Oxford: Elsevier, Churchill, Livingstone. p84.
6. Bracesco N, Candreva EC, Keszenman DJ, Sanchez AG, Soria S, Dell M, Siede W, Nunes E. 2007. Roles of Saccharomyces cerevisiae RAD17 and CHK1 checkpoint genes in the repair of double-strand breaks in cycling cells. Radiation and Environmental Biophysics 46:401-407.
7. Chang DJ, Cimprich KA. 2009. DNA damage tolerance: When it's OK to make mistakes. Nature Chemical Biology 5:82-90.
8. Cline SD, Hanawalt PC. 2006. Topoisomerase deficiencies subtly enhance global genomic repair of ultraviolet-induced DNA damage in Saccharomyces cerevisiae. DNA Repair 5:611-617.
9. Coleman CN. 2001. International Conference on Translational Research and Preclinical Strategies in Radio-Oncology (ICRT) [Conference summary]. International Journal of Radiation Oncology Biology Physics 49:301-309.
10. Coogle JE. 1983. Radiation and cancer. In: Coogle JE, editor. Biological effects of radiation. 2nd ed. London: Taylor & Francis Ltd. p. 170.
11. Degrassi F, Fiore M, Palitti F. 2004. Chromosomal aberrations and genomic instability induced by topoisomerase-targeted antitumor drugs. Current Medicinal Chemistry- Anti-Cancer Agents 4:317-325.
12. Eastman A. 1987. The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexes. Pharmacology & Therapeutics 34:155-166.
13. Friedberg EC, Walker GC, Siede W. 2006. DNA repair and mutagenesis. 2nd ed. Washington DC: ASM Press.
14. Friedl AA, Kiechle M, Fellerhoff B, Eckardt-Schupp F. 1998. Radiation-induced chromosome aberrations in Saccharomyces cerevisiae. Influence of DNA repair pathways. Genetics 148: 975-988.
15. Gallagher WM, Cairney M, Schott B, Roninson IB, Brown R.1997. Identification of p53 genetic suppressor elements which confer resistance to cisplatin. Oncogene 14:185-193.
16. Hartwell LH, Kastan MB. 1994. Cell cycle control and cancer. Science 266:1821-1828.
17. Hartwell LH, Szankasi P, Roberts CJ, Murray AW, Friend SH. 1997. Integrating genetic approaches into the discovery of anticancer drugs. Science 278:1064-1068.
18. Huertas P. 2010. DNA resection in eukaryotes: deciding how to fix the break. Nature Structural &Molecular Biology 17(1):11-16.
19. International Atomic Energy Agency (IAEA). 2002. International Code of Practice for Dosimetry based on Standards of Absorbed Dose to Water. Technical reports series: No. 398.
20. Keszenman D, Candreva E, Nunes E. 2000. Cellular and molecular effects of bleomycin are modulated by heat shock in Saccharomyces cerevisiae. Mutation Research 459:29-41.
21. Keszenman DJ, Candreva EC, Sánchez AG, Nunes E. 2005. RAD6 gene is involved in heat shock induction of bleomycin resistance in Saccharomyces cerevisiae. Environmental and Molecular Mutagenesis 45:36-43.
22. Lillo OL, Severgnini AA, Nunes EM. 1997. Interactive lethal and mutagenic effects of ultraviolet light and bleomycin in yeast: Sinergism or antagonism? Radiation Research 148:476-480.
23. Lillo OL, Bracesco N, Nunes EM. 2007. Interaction between grays, cisplatin and etoposide at cellular and molecular levels. In: 6th International Conference of Biological Physics. International Union for Pure and Applied Biophysics (IUPAB) [Abstract book]. Montevideo, Uruguay p.133.
24. Lowndes NF,Murguia JR. 2000. Sensing and responding to DNA damage. Current Opinion in Genetics & Development 10:17-25.
25. Malik M, Nitiss JL. 2004. DNA repair functions that control sensitivity to topoisomerase-targeting drugs. Eukaryotic Cell 3:82-90.
26. Malik M, Nitiss KC, Enriquez-Rios V, Nitiss JL. 2006. Roles of nonhomologous endjoining pathways in surviving topoisomerase II-mediated DNA damage. Molecular Cancer Therapeutics 5:1405-1414.
27. Manic S, Gatti MS, Carenini N, Fumagalli G, Zunino F, Perego P. 2003. Mechanisms controlling sensitivity to platinum complexes: Role of p53 and DNA mismatch repair. Current Cancer Drug Targets 3:21-29.
28. McANulty MM, Lippard SJ. 1996. The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast. Mutation Research 362:75-86.
29. Milas L, Cox JD. 2003. Clinical applications of combined radiation therapy and chemotherapy. In: Cox JD, Kian Ang K, editors. Radiation oncology: Rationale, technique, results. 8th ed. Philadelphia: Mosby. pp 118-120.
30. Motegi A, Kuntz K, Majeed A, Smith S, Kyungjae Myung K. 2006. Regulation of gross chromosomal rearrangements by ubuquitin and SUMO ligases in Saccharomyces cerevisiae. Molecular and Cellular Biology 26:1424-1433.
31. Nitiss JL. 1998. Investigating the biological functions of DNA topoisomerases in eukaryotic cells. Biochimica et Biophysica Acta 1400:63-81.
32. Nitiss JL. 2009. Targeting DNA topoisomerase II in cancer chemotherapy. Nature Reviews Cancer 9:338-350.
33. Nunes EM, Brum G, Candreva C, Schenberg Frascino AC. 1984. Common repair pathways acting upon UV- and Xray induced damage in diploid cells of Saccharomyces cerevisiae. International Journal of Radiation Biology 45: 593-606.
34. Nunes EM, Candreva EC, Bracesco N, Sanchez A, Dell M. 2008. HDF1 and RAD17 genes are involved in DNA double-strand break repair in stationary phase Saccharomyces cerevisiae. Journal of Biological Physics 34:63-71.
35. Nyberg KA, Michelson RJ, Putnam CW, Weinert TA. 2002. Toward maintaining the genome: DNA damage and replication checkpoint. Annual Review of Genetics 36:617-656.
36. Putnam CD, Pennaneach V, Kolodner R. 2005. Saccharomyces cerevisiae as a model system to define the chromosomal instability phenotype. Molecular and Cellular Biology 25: 7226-7238.
37. Rhind N, Russell P. 2000. Chk1 and Cds1: Linchpins of the DNA damage and replication checkpoint pathway. Journal of Cell Science 113:3889-3896.
38. Salvo VA, Candreva EC, Nunes E. 1998. Rol de la reparacion del ADN y de la topoisomerasa en la resistencia al carboplatino en poblaciones celulares. [Abstract] In: VII Congreso Iberoamericano de Biologia Celular. Montevideo, Uruguay. p.155.
39. Salvo V, Bracesco N, Candreva E, Nunes E. 2001. Mild hyperthermia impairs carboplatin resistance in human ovary tumor cells. [Abstract] Environmental and Molecular Mutagenesis 37:66.
40. Shrivastav M, De Haro LP, Nickoloff JA. 2008. Regulation of DNA double-strand break repair pathway choice. Cell Research 18:134-147.
41. Siede W, Friedl AA, Dianova I, Eckardt-Schupp F, Friedberg EC. 1996. The Saccharomyces cerevisiae Ku autoantigen homologue affects radiosensitivity only in the absence of homologous recombination. Genetics 142:91-102.
42. Zamble DB, Lippard SJ. 1995. Cisplatin and DNA repair in cancer chemotherapy. Trends in Biochemical Sciences 20:435-439.